Center on Health Equity and Access

Clinical

Health Care Cost

Health Care Delivery

Insurance

Policy

Technology

Value-Based Care

News

All News

Partners

Press Releases

Product Approvals and Launches

Media

Clinical Spotlight

Enduring Webinars

Guidelines

Insights

Interviews

Medical World News

Microsites

News Network

OnLocation

Payer Perspectives

Peer Exchange

Podcasts

Post Conference Perspectives

Stakeholder Summit

Week in Review

Conferences

Conference Coverage

Conference Listing

Journals

Submit a Manuscript

All Journals

The American Journal of Managed Care

The American Journal of Accountable Care

Evidence-Based Oncology

Supplements and Featured Publications

Compendia

Alopecia

Asthma

Atopic Dermatitis

Autoimmune

Biosimilars

Breast Cancer

COPD

COVID-19

Cardiovascular

Cholangiocarcinoma

Chronic Kidney Disease

Colorectal Cancer

DLBCL

Dermatology

Diabetes

Digital Health

Duchenne Muscular Dystrophy

Employers

Epilepsy

Gastroenterology

Gene Therapy

Heart Failure

Hemophilia

Immuno-Oncology

Infectious Disease

Inflammation

Leukemia and Lymphoma

Liver

Lung Cancer

Lupus

Major Depressive Disorder

Medicare

Multiple Myeloma

Multiple Sclerosis

Myasthenia Gravis

Myelodysplastic Syndromes

Non-Small Cell Lung Cancer

Obesity

Oncology

Ophthalmology

Ovarian Cancer

Parkinson Disease

Population Health

Prostate Cancer

Psoriasis

Pulmonary Arterial Hypertension

Rare Blood

Rare Disease

Reimbursement

Respiratory

Rheumatology

Skin Cancer

Sleep

Spinal Muscular Atrophy

Type 1 Diabetes

Vaccines

Women's Health

Events

Upcoming Webinars

CME/CE

Resources

Exclusive Content

Formulary Central

Interactive Tools

Subscribe

eNewsletter

As Blue Cross and Blue Shield of North Carolina’s (Blue Cross NC) Vice President of Government Markets: Engagement, Integration and Innovation, Angela leads company efforts to identify and optimize strategic relationships designed to drive growth in government marketsand deliver on the company’s mission to make health care better for all.

This VP role is responsible for leading engagement at the county level across Blue Cross NC’s government lines of business, guiding relationships with local leaders as well as faith-based and tribal organizations to understand local needs and develop tailored solutions. She is also involved in the company’s community work to promote stronger statewide support for children and families in the child welfare system.

In this role, she also helps advance tribal initiatives, engages communities across the state with Blue Cross NC’s corporate centers, and optimizes programs with North Carolina’s colleges and universities. She leads work to reduce gaps in quality and health outcomes, while achieving financial performance goals and overseeing budgeting, cost management and the membership experience within Blue Cross NC’s government lines of business (including Medicaid, Medicare, Federal Employee Program and a dual-eligible special needs plan).

Angela has been a key force in developing, launching, and managing Blue Cross NC’s Healthy Blue Medicaid managed care plan, which went live on July 1, 2021, and now serves over 500,000 members. For several years she served as Healthy Blue’s chief administrative and compliance officer. In that role, she was responsible for providing operational and regulatory oversight of the contract requirements, and she represented Blue Cross NC with regulatory agencies.

Angela now serves as CEO of Healthy Blue, where she leads day-to-day operations and overall strategy for serving Blue Cross NC’s Medicaid members.

A life-long North Carolinian, Angela graduated from Appalachian State University with a Bachelor of Science in communications. In addition to her work for Blue Cross NC, Angela serves her community in several leadership roles and is especially committed to supporting children and adolescents. She sits on the Tammy Lynn Centers Board of Directors, Triangle Family Services Board of Directors, Wake Tech Foundation’s Board of Directors, and Reach Out and Read NC’s Advisory Board. She is also an alumnus of the Leadership North Carolina program.

Articles

The sustained, collaborative effort to expand Medicaid will improve the lives of working North Carolinians who, prior to enactment, earned too much to qualify for Medicaid, but not enough to afford insurance on the marketplace.  

Contributor: North Carolinians Worked Together to Enact Medicaid Expansion. Our Collaboration Can’t End Now.

EG12014, a biosimilar of the anti-HER2 monoclonal antibody trastuzumab, has received a marketing authorization from the European Commission for use in the European Union (EU) for the treatment of patients with HER2-positive (HER2+) breast and metastatic gastric cancer; these are the same indications that trastuzumab holds in the European Union.

Trastuzumab Biosimilar Gets Go Ahead in EU for HER2+ Breast and Metastatic Gastric Cancers

Julia is an associate editor for The American Journal of Managed Care® (AJMC®) and joined AJMC® in 2022. She produces written and video content covering multiple disease states, and assists in the screening process for manuscripts submitted to AJMC®.

She has a BA in English language and literature from Rutgers University. You can connect with Julia on 

Children who took short-term topical atropine eye drops, 0.01% to 1.0%, had no difference in final refractive errors 10 to 20 years after treatment.

Final Refractive Errors in Children Not Associated With Topical Atropine Eye Drops

 She is a proud alumna of the University of Massachusetts. She graduated with degrees in Journalism, Art History, and Environmental Conservation.

Patients with uncontrolled chronic obstructive pulmonary disease (COPD) and type 2 inflammation had significantly better lung function at least a year into a dupilumab regimen.



Data From Phase 3 Trials Demonstrate Efficacy of Dupilumab for Treating COPD, Type 2 Inflammation

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.

About Us

Contact

Editorial Staff

Editorial Boards

Advertise

Do Not Sell My Information

Terms & Conditions

Privacy Policy

AJMC - Managed Care News, Research, and Expert Insights

Facebook

Twitter

LinkedIn

Stakeholders

Academia

Health System

Payers

Providers

Topics

Institute for Value-Based Medicine

All Coverage

Event Coverage

About AJMC

AJMC Journals

Anniversary

Author Forms

Authors

Nominate a Rising Leader

1rem

Higher cost-sharing levels reduced adherence to antidiabetic medications in patients with type 2 diabetes.

Cost Sharing, Adherence, and Health Outcomes in Patients With Diabetes

Berhanu Alemayehu, DrPH

Articles